Please assess the completion status of the following clinical trial:

Trial Title: Subantimicrobial Doxycycline in Acne

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Documented moderate to severe facial acne~Exclusion Criteria:~* Other skin conditions on the face~* Previous antibiotic treatment for acne~* Use of antibiotics for any reason within the past month~* Use of new prescription regiment for acne within the last 3 months~* Positive pregnancy test in the clinic~* Cognitive impairments

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 17 Years
- Healthy Volunteers: t

Study Arms:
- 100 mg standard dose doxycycline BID (Type: ACTIVE_COMPARATOR): Oral, 12 weeks
- 20 mg sub-antimicrobial dose doxycycline BID (Type: EXPERIMENTAL): Oral, 12 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).